Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells
- PMID: 28560289
- PMCID: PMC5439237
- DOI: 10.1016/j.jcmgh.2017.03.003
Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells
Abstract
Gastric cancer is the third most common cause of cancer-related death. Although the incidence of gastric cancer in the United States is relatively low, it remains significantly higher in some countries, including Japan and Korea. Interactions between cancer stem cells and the tumor microenvironment can have a substantial impact on tumor characteristics and contribute to heterogeneity. The mechanisms responsible for maintaining malignant cancer stem cells within the tumor microenvironment in human gastric cancer are largely unknown. Tumor cell and genetic heterogeneity contribute to either de novo intrinsic or the therapy-induced emergence of drug-resistant clones and eventual tumor recurrence. Although chemotherapy often is capable of inducing cell death in tumors, many cancer patients experience recurrence because of failure to effectively target the cancer stem cells, which are believed to be key tumor-initiating cells. Among the population of stem cells within the stomach that may be targeted during chronic Helicobacter pylori infection and altered into tumor-initiating cells are those cells marked by the cluster-of-differentiation (CD)44 cell surface receptor. CD44 variable isoforms (CD44v) have been implicated as key players in malignant transformation whereby their expression is highly restricted and specific, unlike the canonical CD44 standard isoform. Overall, CD44v, in particular CD44v9, are believed to mark the gastric cancer cells that contribute to increased resistance for chemotherapy- or radiation-induced cell death. This review focuses on the following: the alteration of the gastric stem cell during bacterial infection, and the role of CD44v in the initiation, maintenance, and growth of tumors associated with gastric cancer.
Keywords: CD, cluster-of-differentiation; CD44v6; CD44v9; CD44v9, CD44 variant isoform containing exon v9; CSC, cancer stem cell; Cag, cytotoxin-associated gene; Helicobacter pylori; Inflammation; Lgr5, leucine-rich, repeat-containing, G-protein–coupled receptor 5; MDSC, myeloid-derived suppressor cell; PDL1, programmed cell death 1 ligand; PDTX, patient-derived tumor xenograft; ROS, reactive oxygen species; SPEM, spasmolytic polypeptide expressing metaplasia; xCT, SLC7A11.
Figures
Similar articles
-
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.Cancer Sci. 2013 Oct;104(10):1323-9. doi: 10.1111/cas.12236. Epub 2013 Aug 12. Cancer Sci. 2013. PMID: 23848514 Free PMC article.
-
Role of metaplasia during gastric regeneration.Am J Physiol Cell Physiol. 2020 Dec 1;319(6):C947-C954. doi: 10.1152/ajpcell.00415.2019. Epub 2020 Aug 5. Am J Physiol Cell Physiol. 2020. PMID: 32755448 Free PMC article. Review.
-
The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach.Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):605-624. doi: 10.1016/j.jcmgh.2016.05.004. eCollection 2016 Sep. Cell Mol Gastroenterol Hepatol. 2016. PMID: 27990460 Free PMC article.
-
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1. Stem Cells Transl Med. 2015. PMID: 26136504 Free PMC article. Review.
-
Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.Anticancer Res. 2018 Nov;38(11):6163-6170. doi: 10.21873/anticanres.12969. Anticancer Res. 2018. PMID: 30396933
Cited by
-
Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer.Cell J. 2023 Apr 1;25(4):222-228. doi: 10.22074/cellj.2022.557384.1046. Cell J. 2023. PMID: 37210642 Free PMC article.
-
The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.Int J Mol Sci. 2022 Aug 29;23(17):9767. doi: 10.3390/ijms23179767. Int J Mol Sci. 2022. PMID: 36077165 Free PMC article.
-
The immune microenvironment in gastric adenocarcinoma.Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):451-467. doi: 10.1038/s41575-022-00591-0. Epub 2022 Mar 14. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35288702 Free PMC article. Review.
-
The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway.Int J Clin Oncol. 2022 May;27(5):911-920. doi: 10.1007/s10147-022-02123-x. Epub 2022 Feb 5. Int J Clin Oncol. 2022. PMID: 35122587
-
Loss of Tight Junction Protein Claudin 18 Promotes Progressive Neoplasia Development in Mouse Stomach.Gastroenterology. 2018 Dec;155(6):1852-1867. doi: 10.1053/j.gastro.2018.08.041. Epub 2018 Sep 7. Gastroenterology. 2018. PMID: 30195448 Free PMC article.
References
-
- Ferlay J., Soerjomataram I., Dikshit R. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. - PubMed
-
- Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. - PubMed
-
- Neugut A.I., Hayek M., Howe G. Epidemiology of gastric cancer. Semin Oncol. 1996;23:281–291. - PubMed
-
- Covacci A., Telford J.L., Del Giudice G. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328–1333. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous